References
- 1. Statista Inc. (2017). Top 10 biotech and Pharmaceutical Companies Worldwide Based on Market Value in 2016 (in billion U.S. dollars). Retrieved March 15, 2017, from https://www.statista.com/statistics/272716/global-top-biotech-andpharmaceutical-companies-based-on-market-value/
- 2. Kesic, D. (2011). Pharmaceutical Industry in Strategic Development. International Jounral of Economics and Resarch. 2(6), 29-37.
- 3. Cubisms. (2012, August). Pharmaceutical Supply Chain Risk Management. Retrieved April 08, 2015 from http://www.mypurchasingcenter.com/files/2313/4678/0641/PharmaceuticalSupplyChainRiskManagement.pdf
- 4. Breen, L. (2008). A Preliminary Examination of Risk in the Pharmaceutical Supply Chain (PSC) in the National Health Service (NHS) (UK). Journal of Service Science and Management. 1(2), 193-199.
- 5. Jaberidoost, M., Nikfar, S., Abdollahiahiasl, A. & Dinarvand R. (2013). Pharmaceutical supply chain risks: a sistematic review. DARU Journal of Pharmaceutical Sciences. 21(69), 1-7. DOI: 10.1186/2008-2231-21-69.
- 6. Brako, S., Asante, D. & Akosah, N.B. (2016). Investigating the Risks in the Pharmaceutical Supply Chain in Ghana. International Journal of Academic research in Business and Social Sciences. 6(6), 7-21. DOI: 10.6007/IJARBSS/v6-i6/2176.
- 7. Kamath, J.K., Kamath, K.K., Azaruddin, M., Subrahmanyam, E.V.S. & Shabharaya, A.R. (2012). Evaluation of Different Types of Risks in Pharmaceutical Supply Chain. American Journal of PharmTech Research. 2(4), 280-287.
- 8. KPMG International. (2009). Risk Management in the Pharmaceuticals and Life Sciences Industry. Retrieved March 20, 2015 from https://www.eiuperspectives.economist.com/sites/default/files/Risk%20management%20in%20the%20pharmaceuticals%20and%20life%20sciences%20industry.pdf
- 9. Jeberidoost, M., Olfat, L., Hosseini, A., Kabriaeezadeh, A., Abdollahi, M., Alaeddini, M. & Dinarvand, R. (2015). Pharmaceutical Supply Chain Risk Assessment in Iran Using Analytic Hierarchy Process (AHP) and Simple Additive Weighting (SAW) Methods. Journal of Pharmaceutical Policy and Practice. 8(9), 1-10. DOI: 10.1186/s40545-015-0029-3.
- 10. Enyinda, C., Briggs, C. & Backhar, K. (2009). Managing Risk in Pharmaceutical Global Supply Chain Outsourcing. In ASBBS Annual Conference, 19-22 February 2009. Las Vegas, Nevada: Proceedings of ASBBS.
- 11. Logozar, K. (2004). Poslovna logistika: Elementi in podsistemi. Ljubljana: GV izobrazevanje.
- 12. Jereb, B., Ivanusa, T. & Rosi, B. (2013). Systemic Thinking and Requisite Holism in Mastering Logistics Risks: the Model for Identifying Risks in Organisations and Supply Chain. Amfiteatru Economic. 15(33), 56-73.
- 13. ISO. (2009). ISO 31000:2009 Risk Management - Principles and Guidelines. Retrieved June 08, 2015, from https://www.iso.org/obp/ui/#iso:std:iso:31000:ed-1:v1:en
- 14. Jereb, B. (2014). Upravljaje Tveganj. Celje: University in Maribor - Faculty of logistics.
- 15. Jereb, B. & Cvehte, T. (2013). Risk Catalog. Retrieved April 04, 2015 from http://labinf.fl.uni-mb.si/risk-catalog/
- 16. ISO. (2009). Risk Management - Risk Assessment Techniques. Retrieved June 10, 2015, from https://www.iso.org/obp/ui/#iso:std:iec:31010:ed-1:v1:en
- 17. JAZMP. (2016, October). List of Holders of Licence for Performing the Activity of Wholesaler in Medicinal Products. Retrieved June 30, 2015, from https://www.jazmp.si/fileadmin/datoteke/seznami/ImetnikiDovoljenjNaDebeloo.pdf
- 18. European Medicines Agency. (2012, November). Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing / Good Manufacturing Practice Compliance Problems. Retrieved April 09, 2015, from http://www.ema.europa.eu/docs/en_GB/document_library/Other/2012/11/WC500135113.pdf
- 19. Waters, D. (2011). Supply Chain Risk Management. Vulnerability and Resilience in Logistics. London: Kogan Page Limited.